Search results
Results From The WOW.Com Content Network
Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. [3] [4] One of the world's largest independent biotechnology companies, As of 2022, Amgen has approximately 24,000 staff in total. [5]
During Bradway’s tenure as CEO, Amgen's annual revenue increased from $17.3 billion in 2012 to $26 billion in 2021, and annual R&D investment increased to $4.2 billion in 2020. Bradway oversaw the acquisition of Iceland-based DeCODE Genetics in 2012, [10] Onyx Pharmaceuticals in 2013, [11] and a 20.5% equity stake in Beijing-based BeiGene in ...
Kevin W. Sharer (born March 2, 1948), is an American businessman who was chairman/CEO of the biotechnology company Amgen from 2000 to 2012. He later joined the faculty of Harvard Business School teaching RC Strategy and General Management. [1] [2] [3]
Nancy Hopkins (scientist) Nancy Hopkins, an American molecular biologist, ( née Doe, born June 16, 1943) is the Amgen, Inc. Professor of Biology at the Massachusetts Institute of Technology. [1] [2] She is a member of the National Academy of Sciences, the Institute of Medicine of the National Academy, and the American Academy of Arts and Sciences.
On Tuesday, Amgen Inc. (NASDAQ:AMGN) reported second-quarter sales of $8.39 billion, up 20% year over year and beating the consensus of $8.33 billion. Product sales grew 20%, driven by 26% volume ...
Alan J. Russell. Alan J. Russell (born August 8, 1962 in Salford, Greater Manchester UK), is Vice President of Biologics for Amgen, one of the world’s leading Biopharmaceutical companies. Until 2020, Alan was the Highmark Distinguished Career Professor and Director of the Disruptive Health Technology Institute at Carnegie Mellon University.
The U.S. Food and Drug Administration on Thursday granted accelerated approval to Amgen's tarlatamab, a targeted immunotherapy for adults in the advanced stages of hard-to-treat small cell lung ...
This page was last edited on 12 August 2008, at 04:49 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may ...